| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cullinan Therapeutics, Inc. | Director | Common Stock | 187K | $2.43M | $13.00 | 10 Jun 2024 | Direct |
| Cullinan Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 0 | 10 Jun 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CGEM | Cullinan Therapeutics, Inc. | 10 Jun 2024 | 2 | $240K | 4 | Director | 11 Jun 2024, 18:00 |
| CGEM | Cullinan Therapeutics, Inc. | 23 May 2024 | 4 | $572K | 4 | Director | 23 May 2024, 16:11 |
| CGEM | Cullinan Oncology, Inc. | 08 Jun 2023 | 1 | $0 | 4 | Director | 12 Jun 2023, 17:58 |
| CGEM | Cullinan Oncology, Inc. | 22 Jun 2022 | 1 | $0 | 4 | Director | 23 Jun 2022, 18:23 |
| CGEM | Cullinan Oncology, Inc. | 16 Sep 2021 | 1 | $0 | 4 | Director | 25 Mar 2022, 19:35 |